Fig. 2From: Time-dependent LPS exposure commands MSC immunoplasticity through TLR4 activation leading to opposite therapeutic outcome in EAELong LPS exposure significantly increases the therapeutic efficacy of MSC. MSCs were priming in the presence or absence of LPS for 1, 24, and 48 h and coculture with splenocytes that were previously stained with the fluorescent dye CellTrace Violet (CTV) and activated for 72 h with concanavalin A (ConA, 1 μg/ml). a Representative histogram analysis of T cell proliferation by flow cytometry. b Percentage of CD3+ T cells proliferation (%) after coculture with or without MSCs. Data are expressed as mean ± SEM; n = 3, N = 3 biological replicates; *p < 0.05, **p < 0.01. Statistical analysis was performed by one-way ANOVA, Kruskal-Wallis ad hoc post test. c, d EAE in vivo model: MSCs after priming with LPS (500 ng/m for 1 and 24 or 48 h) were injected 7 days after EAE induction. Clinical symptoms and weight loss were evaluated daily. c Clinical score and d cumulative clinical score are shown. Representative data of three independent experiments. Data are expressed as mean ± SEM; n = 12. * symbol represent the comparison between EAE control group and those groups treated with MSCs (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001). δ symbol represent the comparison of EAE+MSCs group versus LPS-treated MSCs groups. (δδ < 0.01). Statistical analysis was performed by c two-way ANOVA or d one-way ANOVA, Kruskal-Wallis ad hoc post testBack to article page